Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
House OKs narrowly defined hemp-extract waiver for some children with intractable epilepsy
Summary
The Utah House passed Seventh Substitute House Bill 105 to allow a one-year, doctor-recommended waiver for a hemp-derived extract (≤0.3% THC, ≥0.15% CBD) for qualified patients with intractable epilepsy and to authorize university research on industrial hemp; the measure passed 62–11.
The Utah House on March 3 approved Seventh Substitute House Bill 105, a two-part measure that lets qualified Utah residents import a narrowly defined hemp extract for patients with intractable epilepsy and allows university research into industrial hemp.
Representative John Frower (speaker on HB 105) told the House the bill creates “a waiver for a qualified Utah citizen to import this hemp product” and requires a board-certified neurologist’s recommendation, lab certification of cannabinoid content and a one-year waiver period administered by the Utah Department of Health. He said the extract is limited to 0.3% or…
Already have an account? Log in
Subscribe to keep reading
Unlock the rest of this article — and every article on Citizen Portal.
- Unlimited articles
- AI-powered breakdowns of topics, speakers, decisions, and budgets
- Instant alerts when your location has a new meeting
- Follow topics and more locations
- 1,000 AI Insights / month, plus AI Chat
